Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nahdi Medical CoSAU:4164 +0.44%55 Return-on-Tangible-Equity is 36.09% as of Mar. 2026, which is 7% below its 10-year median of 38.74. GuruFocus rates SAU:4164 with a GF Score™ of 55/100 and a GF Value™ of ﷼141.92 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 584 Healthcare Providers & Services companies, Nahdi Medical Co ranks better than 78.25% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Nahdi Medical Co's annualized net income for the quarter that ended in Mar. 2026 was ﷼943 Mil. Nahdi Medical Co's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ﷼2,612 Mil. Therefore, Nahdi Medical Co's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 36.09%.
The historical rank and industry rank for Nahdi Medical Co's Return-on-Tangible-Equity or its related term are showing as below:
SAU:4164'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 31.99 Med: 38.74 Max: 52.11
Current: 32.01
During the past 5 years, Nahdi Medical Co's highest Return-on-Tangible-Equity was 52.11%. The lowest was 31.99%. And the median was 38.74%.
SAU:4164's Return-on-Tangible-Equity is ranked better than 78.25% of 584
companies
in the Healthcare Providers & Services industry
Industry Median: 10.815
vs SAU:4164: 32.01
Nahdi Medical Co (SAU:4164) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Nahdi Medical Co Return-on-Tangible-Equity Related Terms
Nahdi Medical Co Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Nahdi Medical Co's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nahdi Medical Co Return-on-Tangible-Equity Competitor Comparison
For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nahdi Medical Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Nahdi Medical Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 36.09% mean?
Nahdi Medical Co (SAU:4164) has a Return-on-Tangible-Equity of 36.09% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Nahdi Medical Co and its competitors. This is near median its historical median of 38.74. Over the past decade, Nahdi Medical Co's Return-on-Tangible-Equity has ranged from 31.99 to 52.11. According to the industry distribution chart, Nahdi Medical Co ranks #127 out of 584 companies in the Healthcare Providers & Services industry, placing it in the top 21.7%.
Is Nahdi Medical Co's Return-on-Tangible-Equity too high?
Nahdi Medical Co's current Return-on-Tangible-Equity of 36.09% is near median its 10-year median of 38.74. Over the past 10 years, this metric has ranged from a low of 31.99 to a high of 52.11. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.82. Nahdi Medical Co's value of 36.09% is 233.7% above this industry median. Based on the distribution chart, Nahdi Medical Co ranks #127 out of 584 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nahdi Medical Co has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Nahdi Medical Co ranks #127 out of 584 companies for Return-on-Tangible-Equity. This places Nahdi Medical Co in the top 22% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.82. Nahdi Medical Co's value of 36.09% is 233.7% above this benchmark. Historically, Nahdi Medical Co's own Return-on-Tangible-Equity has ranged from 31.99 to 52.11 over the past decade. While the company's 10-year median is 38.74 vs. the industry median of 10.82, Nahdi Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.82, based on 584 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nahdi Medical Co's current Return-on-Tangible-Equity of 36.09% is 233.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Nahdi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nahdi Medical Co's current Return-on-Tangible-Equity is 36.09%, which is near median its own 10-year median of 38.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼141.92, compared to a current price of ﷼92.10 — trading 35.1% below its estimated fair value. The current Return-on-Tangible-Equity is 36.09%, which is near median its 10-year median of 38.74 and 233.7% above the Healthcare Providers & Services industry median of 10.82. Nahdi Medical Co's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current Return-on-Tangible-Equity is 36.09% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?
Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued.
The current stock price of ﷼92.10 is trading 35.1% below its estimated GF Value™ of ﷼141.92.
GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:4164:
Return-on-Tangible-Equity: 36.09% (near median its 10-year median of 38.74)
GF Value™: ﷼141.92 vs. price of ﷼92.10 (35.1% below fair value)
Industry Position: 233.7% above the Healthcare Providers & Services median (#127 of 584)
No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
55GF Score
Get the complete analysis for SAU:4164
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4164 has been successfully added to your 
